Alentemol

{{Short description|Selective dopamine autoreceptor agonist}}

{{Chembox

| Name =

| ImageFile = alentemol.svg

| ImageSize = 150px

| IUPACName = 2-(Dipropylamino)-2,3-dihydro-1H-phenalen-5-ol

| OtherNames =

|Section1={{Chembox Identifiers

| Abbreviations =

| CASNo = 112891-97-1

| CASNo_Ref = {{cascite|correct|CAS}}

| UNII_Ref = {{fdacite|correct|FDA}}

| UNII = F6S91MHL3E

| EINECS =

| PubChem = 60574

| ChemSpiderID = 54603

| SMILES = CCCN(CCC)C1CC2=CC=CC3=CC(=CC(=C23)C1)O

| InChI = 1/C19H25NO/c1-3-8-20(9-4-2)17-10-14-6-5-7-15-12-18(21)13-16(11-17)19(14)15/h5-7,12-13,17,21H,3-4,8-11H2,1-2H3

| InChIKey = TWUJBHBRYYTEDL-UHFFFAOYAC

| StdInChI = 1S/C19H25NO/c1-3-8-20(9-4-2)17-10-14-6-5-7-15-12-18(21)13-16(11-17)19(14)15/h5-7,12-13,17,21H,3-4,8-11H2,1-2H3

| StdInChIKey = TWUJBHBRYYTEDL-UHFFFAOYSA-N

| RTECS =

| MeSHName =

| ChEBI =

| ChEMBL = 2104081

| KEGG =

}}

|Section2={{Chembox Properties

| C=19 | H=25 | N=1 | O=1

| Appearance =

| Density =

| MeltingPt =

| MeltingPt_notes =

| BoilingPt =

| BoilingPt_notes =

| Solubility =

| SolubleOther =

| Solvent =

| LogP =

| VaporPressure =

| HenryConstant =

| AtmosphericOHRateConstant =

| pKa =

| pKb =

}}

|Section3={{Chembox Structure

| CrystalStruct =

| Coordination =

| MolShape =

}}

|Section4={{Chembox Thermochemistry

| DeltaHf =

| DeltaHc =

| Entropy =

| HeatCapacity =

}}

|Section5={{Chembox Pharmacology

| AdminRoutes =

| Bioavail =

| Metabolism =

| HalfLife =

| ProteinBound =

| Excretion =

| Legal_status =

| Legal_US =

| Legal_UK =

| Legal_AU =

| Legal_CA =

| Pregnancy_category =

| Pregnancy_AU =

| Pregnancy_US =

}}

|Section6={{Chembox Explosive

| ShockSens =

| FrictionSens =

| DetonationV =

| REFactor =

}}

|Section7={{Chembox Hazards

| ExternalSDS =

| MainHazards =

| NFPA-H =

| NFPA-F =

| NFPA-R =

| NFPA-S =

| FlashPt =

| AutoignitionPt =

| ExploLimits =

| LD50 =

| PEL =

}}

|Section8={{Chembox Related

| OtherAnions =

| OtherCations =

| OtherFunction =

| OtherFunction_label =

| OtherCompounds =

}}

}}

Alentemol (INN) (developmental code name U-66444B), or alentamol, is a selective dopamine autoreceptor agonist described as an antipsychotic, which was never marketed.{{cite book|author=William Andrew Publishing|title=Pharmaceutical Manufacturing Encyclopedia, 3rd Edition|url=https://books.google.com/books?id=_J2ti4EkYpkC&pg=PA143|date=22 October 2013|publisher=Elsevier|isbn=978-0-8155-1856-3|pages=143–}}{{cite book|author=A.F. Casy|title=The Steric Factor in Medicinal Chemistry: Dissymmetric Probes of Pharmacological Receptors|url=https://books.google.com/books?id=-mQFCAAAQBAJ&pg=PA178|date=11 November 2013|publisher=Springer Science & Business Media|isbn=978-1-4899-2397-4|pages=178–}}

See also

References

{{Reflist}}

{{Antipsychotics}}

{{Dopaminergics}}

Category:Abandoned drugs

Category:Antipsychotics

Category:Dipropylamino compounds

Category:Dopamine agonists

{{nervous-system-drug-stub}}